Telefon: *0411, 32705
Supervisor: PAPP, András
Over the last 30 years, the benefits of surgical resection for liver metastases have been established. Actually, surgical resections are feasible with a very low mortality and a 5-year survival that approaches 40 %. But surgery is feasible in only 10 % to 20 % of the patients. Recent progresses in the field of chemotherapy and the development of ablative techniques increases the number of patients that could be operated with a curative intent. During this work we have to analyses our patients’ data who were underwent liver resections for metastasis, and we have to identify factors, which can predict the survival.